Status:
UNKNOWN
Virtual Reality Pain Study
Lead Sponsor:
Baylor Research Institute
Conditions:
Hospitalized Patients 18 Years of Age or Older With Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigating pain in hospitalized patients in two groups: virtual reality usage group vs standard of care
Detailed Description
Patients will be randomized to either the virtual reality group or the standard of care group. The virtual reality group will use the device over two days. Both groups will answer questionnaires regar...
Eligibility Criteria
Inclusion
- • patients at least 18 years of age,
- reported pain in last 24 hours ≥ 3 on the Numerical Rating Scales (NRS),
- patients undergoing surgery,
- expected hospital length of stay of at least 48 hours,
- English fluency,
- willing to comply with study procedures.
- Hx opioid use
Exclusion
- • gross cognitive impairment that would interfere with the ability to consent or complete study procedures
- current or prior diagnosis of epilepsy, seizure disorder, dementia, or migraines,
- hypersensitivity to flashing light or motion,
- history of motion sickness or cyber sickness,
- medical condition predisposing to or current nausea, vomiting or dizziness,
- stereoscopic vision or severe hearing impairment,
- injury to eyes, face or neck that impedes comfortable use of virtual reality,
- cancer related pain,
- PHQ-9 screen indicating suicidal ideation, patients will be referred to appropriate clinical intervention (see suicide protocol)
- currently pregnant,
- current or recent completion of participation in any interventional pain study (with in past 2 months)
- substance abuse (alcohol or illegal drugs): Alcohol- NIAAA definition of heavy drinking as more than 4 drinks on any day or more than 14 drinks per week for men, more than 3 drinks on any day or more than 7 drinks per week for women. Any illegal drugs including marijuana
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05293275
Start Date
March 15 2022
End Date
October 1 2023
Last Update
March 24 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Institute for Rehabilitation
Dallas, Texas, United States, 75246
2
Baylor University Medical Center
Dallas, Texas, United States, 75246
3
Baylor Scott and White Hospital-Temple
Temple, Texas, United States, 76508